Filed in archive
Diagnostics
, Studies
by Gloria Gamat on February 25, 2007

AspenBio Pharma, Inc. (OTC: APNB), an emerging bio-pharmaceutical company dedicated to the development of novel drugs and diagnostics for animals and humans, have developed a diagnostic product for human appendicitis called AppyScore™.
In the past 30 months, AppyScore™ has already been tested in three studies and with one more still ongoing that involves 400 patients. As revealed by AspenBio, the AppyScore™ blood test appears to be able to identify appendicitis in patients at a high sensitivity level of 94-97%.
There is an overwhelming need for more accurate, faster, and less costly technologies for detecting appendicitis and AspenBio hopes to fill that need once AppyScore™ successfully pass clinical trials, FDA-approved and released to the market.
Find more information from AspenBio's press release.
Trackback: http://publish.creative-weblogging.com/publish/mt-tb.pl/55184
Mr Wong
Vote for Novel Blood Test for Human Appendicitis, Showing Accuracy in Clinical Trials:
|
Rating: 6.50 out of 4 vote(s) cast.
|
Subscribe
Use the search to look for other interesting posts
| RSS | See all blog subscribe options |
|
What is RSS? | |
| Yahoo! |
|
| Addthis |
|
| Bloglines |
|
| Newsletter | |
| Follow us on Twitter! |









